Intelligent Substrates, Inc.
ISI is located in the Harbor Enterprise Center in the old Atlantic Southwestern Broom Factory in Baltimore.
Intelligent Substrates, Inc., (ISI) was established in 2007 to develop and bring to market next generation tools for in vitro cell culture. The centerpiece of modern biomedical research, in vitro cell culture plays a critical role in cell biology, tissue engineering, toxicity testing, and drug development. With greater capabilities than current cell culture platforms, ISI's new and advanced cell culture technologies give researchers unprecedented control and access to the cellular microenvironment.
ISI has an exclusive worldwide license for the robust and flexible patterning technology behind the BioWrite™ stock and custom substrates.
The ISI team
Dr. Will Heinz, President and CEO of ISI, has a Ph.D. in biophysics from Johns Hopkins University. He has extensive experience with nanotechnology, single molecule optics, and cell biology. He is a co-inventor of ISI’s primary patent-pending technology.
Dr. Jan Hoh, a co-founder of ISI and an Associate Professor in the Department of Physiology at Johns Hopkins University School of Medicine, is a co-inventor of ISI’s patterning technology. He is an expert in nano- and biotechnology and a consultant to the company.
Mr. Gautam Saxena, CFO of ISI, has run several smaller highly profitable companies, most recently a software consulting business.